UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000009828
Receipt number R000011483
Scientific Title Phase II Study of Bevacizumab in Combination with First-line Platinum-Doublet Chemotherapy in Non-squamous NSCLC Patients with Asymptomatic Untreated Brain Metastases.
Date of disclosure of the study information 2013/01/22
Last modified on 2019/01/27 22:34:18

No. Disposal Last modified on Item of update
1 Insert 2013/01/21 13:46:29
2 Update 2013/09/05 18:15:54 Anticipated trial start date
3 Update 2014/01/22 08:48:44 TEL
Email
Address
TEL
Email
4 Update 2017/07/26 10:31:14 Name of primary person or sponsor
Organization
5 Update 2019/01/27 22:34:18 Recruitment status